- Home
- ABEO vs SABA Comparison
ABEO vs SABA Comparison
Compare ABEO & SABA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABEO
- SABA
- Stock Information
- Founded
- ABEO N/A
- SABA 1988
- Country
- ABEO United States
- SABA United States
- Employees
- ABEO N/A
- SABA N/A
- Industry
- ABEO Biotechnology: Pharmaceutical Preparations
- SABA
- Sector
- ABEO Health Care
- SABA
- Exchange
- ABEO Nasdaq
- SABA Nasdaq
- Market Cap
- ABEO 237.4M
- SABA 233.0M
- IPO Year
- ABEO 1980
- SABA N/A
- Fundamental
- Price
- ABEO $4.92
- SABA $8.08
- Analyst Decision
- ABEO Strong Buy
- SABA
- Analyst Count
- ABEO 5
- SABA 0
- Target Price
- ABEO $17.00
- SABA N/A
- AVG Volume (30 Days)
- ABEO 834.1K
- SABA 290.0K
- Earning Date
- ABEO 05-14-2025
- SABA 01-01-0001
- Dividend Yield
- ABEO N/A
- SABA 12.91%
- EPS Growth
- ABEO N/A
- SABA N/A
- EPS
- ABEO N/A
- SABA N/A
- Revenue
- ABEO N/A
- SABA N/A
- Revenue This Year
- ABEO N/A
- SABA N/A
- Revenue Next Year
- ABEO $539.93
- SABA N/A
- P/E Ratio
- ABEO N/A
- SABA N/A
- Revenue Growth
- ABEO N/A
- SABA N/A
- 52 Week Low
- ABEO $3.05
- SABA $3.64
- 52 Week High
- ABEO $8.45
- SABA $4.42
- Technical
- Relative Strength Index (RSI)
- ABEO 51.29
- SABA 39.31
- Support Level
- ABEO $3.93
- SABA $8.10
- Resistance Level
- ABEO $5.02
- SABA $8.40
- Average True Range (ATR)
- ABEO 0.41
- SABA 0.28
- MACD
- ABEO 0.06
- SABA 0.00
- Stochastic Oscillator
- ABEO 90.83
- SABA 33.33
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel AIM.
About SABA Saba Capital Income & Opportunities Fund II Shares of Beneficial Interest
Saba Capital Income & Opportunities Fund II is a closed-end fund. The company seeks high current income, with a secondary goal of capital appreciation. The fund invests in fixed income markets across the globe.